Angiotensin II type 1 receptor gene polymorphism is associated with an increased vascular reactivity in the human mammary artery in vitro

Journal of Vascular Research

Volumn 35, Issue 5, 1998, Pages 356-362

  Henrion, Daniel ^a,d   Amant, C ^c   Benessiano, Joëlle ^b   Philip, I ^b   Plantefeve, G ^b   Chatel, D ^b   Hwas, Ulrich ^b   Desmont, J M ^b   Durand, Geneviève ^b   Amouyel, P ^c   Lévy, Bernard I ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b BICHAT HOSPITAL   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d INSERM   (France)

Author keywords

Angiotensin II; AT1 receptor; Blood vessels; Phenylephrine

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; PHENYLEPHRINE;

ALPHA ADRENERGIC STIMULATION; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAMMARY ARTERY; PRIORITY JOURNAL; RECEPTOR GENE; SMOOTH MUSCLE CONTRACTION;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARDIOVASCULAR DISEASES; FEMALE; GENOTYPE; HUMANS; MALE; MAMMARY ARTERIES; MIDDLE AGED; PHENYLEPHRINE; POINT MUTATION; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 7844248657     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025605     Document Type: Article

References (29)

1. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-250.
2. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser A, Tiret L, Cambien F, Corvol P, Soubrier F: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994;24:63-69.
3. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marquez-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetière F, Soubrier F, Cambien F: Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-913.
4. Benetos A, Gauthier S, Richard S, Topouchian J, Asmar R, Poirier O, Lorosa E, Guize L, Safar M, Soubrier F, Cambien F: Influence of the angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996;94:698-703.
5. Amant C, Hamon M, Bauters C, Richard F, Helbecque N, McFadden EP, Escudo X, Lablanche JM, Amouyel P, Bertrand P: The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 1997;29:486-490.
6. Simon D, Romestand B, Huang H, Badouaille G, Fehrentz JA, Bau P, Marchand J, Corvol P: Direct, simplified and sensitive assay of angiotensin II in plasma extracts performed with a high-affinity monoclonal antibody. Clin Chem 1992;38:1963-1967.
7. Day MD, Moore AF: Interaction of angiotensin II with noradrenaline and other spasmogens on rabbit isolated aortic strips. Arch Int Pharmacodyn Thér 1987;219:29-35.
8. Lyons D, Webster J, Benjamin N: Angiotension II: Adrenergic sympathetic constrictor actions in humans. Circulation 1995;91:1457-1460.
9. 2+ influx: Role of protein kinase C. J Pharmacol Exp Ther 1992;261:835-842.
10. Laher I, Thompson LP, Gagne L: Protein kinase C as a modulator of response amplification in vascular smooth muscle. Blood Vessels 1990;27:333-340.
11. Qiu HY, Henrion D, Lévy BI: Endogenous angiotensin II potentiates phenylephrine-induced tone in normotensive and hypertensive rats. Hypertension 1994;24:317-321.
12. Seidelin PH, Collier JG, Struthers AD, Webb DJ: Angiotensin II augments sympathetically mediated arteriolar construction in man. Clin Sci 1991;81:261-266.
13. Henrion D, Laher I, Laporte R, Bevan JA: Further evidence from an elastic artery that angiotensin II amplifies noradrenaline-induced contraction through activation of protein kinase C. Eur J Pharmacol 1992;224:13-20.
14. Weber MA, Purdy RE, Stupecky SL, Prins BA: Augmentation of sympathomimetic arterial contraction by angiotensin II: A novel mechanism. J Vasc Med Biol 1989;1:7-15.
15. Duckles SP: Angiotensin II potentiates responses of the rabbit basilar artery to adrenergic nerve stimulation. Life Sci 1981;28:40-47.
16. Dowell FJ, Henrion D, Benessiano J, Poitevin P, Lévy BI: Chronic infusion of low dose angiotensin II potentiates the in vitro adrenergic response. J Hypertens 1996;14:177-182.
17. Vanhoutte PM, Verbeuren TJ, Webb RC: Local modulation of adrenergic neuroeffector interaction in the blood vessel wall. Physiol Rev 1981;61:151-159.
18. Haynes WG, Hand MF, Johnstone HA, Padfield PL, Webb DJ: Direct and sympathetically mediated venoconstriction in essential hypertension. J Clin Invest 1993;94:1359-1364.
19. Smith DHG, Neutel JM, Weber MA: Effects of angiotensin II on pressure responses to norepinephrine in human. Life Sci 1991;48:2413-2421.
20. Henrion D, Laher I: Potentiation of norepinephrine-induced contractions by endothelin-1 in the rabbit aorta. Hypertension 1993;22:78-83.
21. Michaelis L, Menten T: Die Kinetik der Invertinwirkung. Biochem Z 1993;49:333-342.
22. Leadon SA, Cerutti PA: A rapid and mild procedure for the isolation of DNA from mammalian cells. Anal Biochem 1992;120:282-288.
23. Castellano M, Muiesan ML, Beschi M, Rizzoni D, Cinelli A, Salvati M, Pasisni G, Porteri E, Bettoni G, Zulli RA, Gabiti-Rosei E: Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure. Hypertension 1996;28: 1076-1080.
24. Wang WY, Zee RY, Morris BJ: Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet 1997;51:31-34.
25. Takami S, Katsuya T, Rakugi H, Sato N, Nakata Y, Kamitani A, Miki T, Higaki J, Ogihara T: Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens 1998;11:316-321.
26. Schmidt S, Beige J, Walla-Friedel M, Michel MC, Sharma AM, Ritz E: A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens 1997;15:1385-I388.
27. Kähönen M, Arvolla P, Mäkinen H, Pörst I: Antihypertensive therapy and arterial function in experimental hypertension. Gen Pharmacol 1996;27:221-238.
28. Chin JPF, Dart AM: Hypertension; in Garland CJ, Angus JA (eds): Pharmacology of Vascular Smooth Muscle. Oxford, Oxford University Press, 1996, pp 387-401.
29. Henrion D, Benessiano J, Lévy BI: In vitro modulation of a resistance artery diameter by the tissue renin-angiotensin system of a donor artery. Circ Res 1997;80:189-195.